APA (7th ed.) Citation

Lee, B., Kim, D. G., Lee, A., Kim, Y. M., Cui, L., Kim, S., & Choi, I. (2023). Synthesis and discovery of the first potent proteolysis targeting chimaera (PROTAC) degrader of AIMP2-DX2 as a lung cancer drug. Journal of Enzyme Inhibition & Medicinal Chemistry, 38(1), 51. https://doi.org/10.1080/14756366.2022.2135510

Chicago Style (17th ed.) Citation

Lee, BoRa, Dae Gyu Kim, Aram Lee, Young Mi Kim, Lianji Cui, Sunghoon Kim, and Inhee Choi. "Synthesis and Discovery of the First Potent Proteolysis Targeting Chimaera (PROTAC) Degrader of AIMP2-DX2 as a Lung Cancer Drug." Journal of Enzyme Inhibition & Medicinal Chemistry 38, no. 1 (2023): 51. https://doi.org/10.1080/14756366.2022.2135510.

MLA (9th ed.) Citation

Lee, BoRa, et al. "Synthesis and Discovery of the First Potent Proteolysis Targeting Chimaera (PROTAC) Degrader of AIMP2-DX2 as a Lung Cancer Drug." Journal of Enzyme Inhibition & Medicinal Chemistry, vol. 38, no. 1, 2023, p. 51, https://doi.org/10.1080/14756366.2022.2135510.